During the year, a large number of core technical personnel of pharmaceutical companies resigned, and there is no shortage of those with annual salary of nearly one million

On the evening of August 1, Kain Technology announced that Hou Jianhua, the company's core technical staff, resigned due to personal reaso.
According to the company's 2021 financial report, Hou Jianhua's annual salary before tax is nearly one million, reaching 923,400 yu.
It is worth mentioning that Kain Technology has left two core technicians this ye.
Except for Hou Jianhua, in February this year, the company announced that the core technician Xu Zheng resigned due to personal reaso.
Up to now, there are 6 people in the core technical team of Kain Technolo.
The company said that at present, Hou Jianhua has completed the work handover with the R&D team, and related R&D projects are in normal progre.
The company's R&D team has a complete structure and sufficient backup personn.
The existing core technical personnel and R&D team can support the company's continuous research and development of core technologies in the futu.
According to the data, Kain Technology is a company that uses biotechnology as a platform, focuses on the field of viruses and immune diseases, and is committed to providing prevention and treatment solutio.
Core technicians are generally responsible for the R&D projects of pharmaceutical companies, mastering patented technologies, e.
, which is an important value of the compa.
The departure of such personnel may have a certain impact on the process of project R&D, and even affect the company's future R&D capabilities, thereby affecting the company's performan.
core competitivene.
Therefore, the change of core technical personnel has attracted much attention in the indust.
Since the beginning of this year, in addition to Kain Technology, a large number of core technical personnel of pharmaceutical companies have left, involving Jindike and so .
On July 7, Kasai Bio released an announcement on the retirement and departure of the company's core technicia.
According to the announcement, .
Chen Wanzhong, the core technician, retired due to age and no longer holds any positions in the compa.
On June 24, Jindike announced that .
Wang Shuo, the company's core technical staff, recently applied for resignation from relevant positions due to personal reasons and completed the resignation procedur.
.
Wang Shuo no longer holds any positions in the compa.
According to the 2021 annual report data, the pre-tax remuneration of Wangshuo is 456,300 yuan
On March 7, Dorui Pharmaceuticals announced that Yao Hongjun, the company's deputy general manager, and Fan der Hua, one of the other core personnel, resigned, while the company's core technician Jane Huang (Huang Weijuan) was also considering applying for resignation in the near future due to personal career planni.
On February 21, Nuotai Biological announced that Ding Jiansheng, the company's core technical staff, resigned recently due to personal reasons and will no longer hold any positions in the company after his resignati.
On February 7, Jiangsu Haooubo Biotechnology announced that .
Zhang Hewen, the company's deputy general manager, core technical staff, and senior vice president of supply chain strategic planning, applied for resignation due to personal reaso.
After his resignation, .
Zhang Hewen will no longer hold other positions in the compa.
On January 12, Sunshine Guojian announced that ZHUZHENPING, the company's director, senior executives and core technicians, resigned from relevant positions due to job adjustment, and will no longer hold any positions in the company after resignati.
In January, Bloomage Bio announced that Li Huiliang, deputy general manager, chief technology officer and core technician, resigned from the company's deputy general manager and chief technology officer due to personal reasons, and no longer served as a core technici.
The subsidiary will no longer hold any positio.
The analysis believes that the current talent mobility in the pharmaceutical industry is relatively strong, and investors should pay more attention to the resignation of core technical backbon.

For pharmaceutical companies, it is particularly important to strengthen the team building of core technicians, establish a sound assessment and reward mechanism, so that core technicians have a sense of identity and belonging, and maintain team stabili.

Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice to anyo.